improving patient outcomes in urothelial carcinoma with novel antibody–drug conjugates
Published 1 year ago • 159 plays • Length 40:12Download video MP4
Download video MP3
Similar videos
-
16:32
new antibodies and antibody-drug conjugates for b-cell lymphoma
-
56:32
antibody drug conjugates for cancer
-
1:28
ocular adverse events with adcs
-
1:37:33
amplifying the adc advantage: adcs as the next frontier in precision lung cancer care
-
1:15
jk06, a biparatopic adc in preclinical development
-
7:06
new hope in cancer treatment! what are antibody-drug conjugates (adcs)
-
2:41
how do antibody-drug conjugates adcs work?
-
0:50
cancer therapy: essential applications of antibody-drug conjugates #cancerresearch #biotech
-
0:57
alex rolland explains new cancer treatment breakthrough: antibody drug conjugates (adcs)
-
1:05:01
tackling the practicalities of antibody–drug conjugate therapy for solid tumors
-
0:46
antibody-drug conjugates in gynecological cancers
-
18:14
in-depth characterization of lysine-conjugated antibody-drug conjugates (adcs) by multiplexed ms/ms
-
1:09
where are we in sequencing adcs in hr breast cancer?
-
7:12
brief introduction of antibody drug conjugates - boc sciences
-
1:26:11
the role of antibody drug conjugates in advanced non-small cell lung cancer
-
21:40
gi medications: antiemetics, acid control and antidiarrheals | advanced em pharmacology workshop
-
16:46
what are antibody drug conjugates (adcs)? 👀 the newest cancer treatment breakthrough – explained!
-
27:03
antibody drug conjugates: the end of chemotherapy | 2023 west oncology conference
-
1:00:29
answers to key questions about antibody–drug conjugates in nsclc